Delivery Order SPE2DB22D3301-SPE2DB25FX3XR
Award Date
10/17/24
Potential Completion Date
10/18/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,240.18 firm fixed-price delivery order is for 4,566,727,569 units of the medication Vyvanse 40 mg capsules. The contract has a ceiling value of $3,240.18 and a completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,079.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,076,036 units of the medication Vyvanse 40 mg capsules. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,103.02 firm fixed-price delivery order is for the supply of 4,568,072,848 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,846.39 firm-fixed-price delivery order is for the supply of 4,565,014,816 units of the medication Vyvanse 40 mg capsules. The contract has a completion date of June 26, 2024 and was awarded on June 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $6,135.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,109,984 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,755.92 fixed-price delivery order covers the supply of 4,567,558,222 units of the pharmaceutical drug Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 firm fixed-price delivery order is for the supply of Vyvanse 40 mg capsules, a medication used to treat ADHD. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,029.85 firm fixed-price delivery order is for the supply of 4,563,802,222 units of Vyvanse 50 mg capsules. The contract has an ultimate completion date of February 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $2,670.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,058,061 units of the medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price contract. This contract award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 firm fixed-price delivery order is for the supply of 4,566,811,822 units of the 50 mg capsule of the drug Vyvanse. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...